Literature DB >> 868900

Mechanisms of resistance to aminoglycosides.

J Davies, P Courvalin.   

Abstract

Bacterial resistance to aminoglycoside antibiotics occurs by a variety of mechanisms. In clinical situations the most common mechanism is plasmid-determined modification of the drug that leads to a block of transport of the antibiotic into the cell. Amikacin, a semisynthetic aminoglycoside, is effective against a number of resistant strains because it has fewer sites of modification.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 868900     DOI: 10.1016/0002-9343(77)90654-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.

Authors:  S J Seligman
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

2.  In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.

Authors:  S A Kabins; C Nathan
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

3.  Which aminoglycoside?

Authors:  A M Emmerson
Journal:  Intensive Care Med       Date:  1980-08       Impact factor: 17.440

4.  In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.

Authors:  H Giamarellou; N P Zissis; G Tagari; J Bouzos
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 5.  Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.

Authors:  P Noone
Journal:  Drugs       Date:  1984-06       Impact factor: 9.546

6.  Induction of streptomycin uptake in resistant strains of Escherichia coli.

Authors:  J V Höltje
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

7.  [Clinical efficacy, nephrotoxicity and ototoxicity of amikacin].

Authors:  P Federspil; K Schindler; C Weich; E Tiesler; W Schätzle; M Ziegler
Journal:  Infection       Date:  1979       Impact factor: 3.553

8.  Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.

Authors:  C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal; R R Packer
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

9.  Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli.

Authors:  M H Perlin; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

10.  Aminoglycoside modification by gentamicin-resistant isolates of Staphylococcus aureus.

Authors:  D F Scott; D O Wood; G H Brownell; M J Carter; G K Best
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.